Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses
NCT ID: NCT05050578
Last Updated: 2023-03-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
166 participants
INTERVENTIONAL
2021-11-02
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Assessment of Two Daily Wear Reusable Soft Silicone Hydrogel Contact Lenses
NCT05056987
Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses
NCT04532099
Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses
NCT04980456
Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
NCT05431478
Clinical Evaluation of a Daily Wear Frequent Replacement Silicone Hydrogel Lens
NCT03920280
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID018869, then AOHP
Lehfilcon A contact lenses worn in Period 1, followed by senofilcon A contact lenses worn in Period 2, as randomized. Each product will be worn in both eyes during waking hours only for at least 10 hours per day for 30 days. CLEAR CARE will be used for daily contact lens cleaning and disinfection.
Lehfilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
Senofilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
AOHP, then LID018869
Senofilcon A contact lenses worn in Period 1, followed by lehfilcon A contact lenses worn in Period 2, as randomized. Each product will be worn in both eyes during waking hours only for at least 10 hours per day for 30 days. CLEAR CARE will be used for daily contact lens cleaning and disinfection.
Lehfilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
Senofilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lehfilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
Senofilcon A contact lenses
Commercially available, silicone hydrogel, spherical contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Manifest cylinder less than or equal to 0.75 diopter in each eye.
* Best corrected distance visual acuity better than or equal to 20/25 Snellen in each eye.
Exclusion Criteria
* Habitual senofilcon contact lens wearer (for example, Acuvue Oasys, Acuvue Vita) or commercially available lehfilcon A contact lens wearer (TOTAL30).
* Routinely sleeps in habitual contact lenses.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sr. Clinical Trial Lead, CDMA Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Elsa Pao, OD
Oakland, California, United States
Pacific Rims Optometry
San Francisco, California, United States
Sabal Eye Care
Longwood, Florida, United States
Vision Health Institute
Orlando, Florida, United States
West Bay Eye Associates
Warwick, Rhode Island, United States
North Spartanburg Eye Center
Boiling Springs, South Carolina, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Advancing Vision Research, LLC
Smyrna, Tennessee, United States
Dr Christina R Chang & Associates, OD, PA
Plano, Texas, United States
Dawn M. Rakich, OD
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLY935-C022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.